Literature DB >> 16460901

Prediction of the permeability of drugs through study on quantitative structure-permeability relationship.

Seo Jeong Jung1, Sun Ok Choi, So Young Um, Joo Il Kim, Hae Young Park Choo, Su Young Choi, Soo Youn Chung.   

Abstract

This study is to research the quantitative structure-permeability relationship of 20 drugs having similar structure. Permeability was determined by using the Caco-2 cell in vitro model. The apparent permeability coefficient (Papp) of each drug both of apical to basolateral side and basolateral to apical side was measured at the concentration corresponding to 0.1 times the highest dose strength of 250 mL dissolved buffer. In order to test the permeability system suitability, we measured the Papp of 19 model drugs out of 20 which presented in 'Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms based on the Biopharmaceutics Classification System' of FDA guidance. Also, we demonstrated the functional expression of efflux systems (e.g., p-gp) by bi-directional transport studies with rhodamine 123. Also, as a result of the study on quantitative structure-permeability relationship by using the partial least square method, it was possible to predict the permeability of drugs from their 3D structure. The quantitative structure-permeability relationship provided a cross-validated q2=0.789, a normal r2=0.998. Considering all of above results, analysis on this quantitative structure-permeability relationship appears to be a very useful tool to predict the permeability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460901     DOI: 10.1016/j.jpba.2005.12.020

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

1.  A general approach to the apparent permeability index.

Authors:  Pasquale Palumbo; Umberto Picchini; Benoît Beck; Jan van Gelder; Nathalie Delbar; Andrea DeGaetano
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-03-20       Impact factor: 2.745

2.  Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

3.  Real-time imaging and quantitative analysis of doxorubicin transport in a perfusable microvessel platform.

Authors:  Max I Bogorad; Peter C Searson
Journal:  Integr Biol (Camb)       Date:  2016-08-15       Impact factor: 2.192

4.  New In Vitro Coculture Model for Evaluating Intestinal Absorption of Different Lipid Nanocapsules.

Authors:  Norraseth Kaeokhamloed; Emillie Roger; Jérôme Béjaud; Nolwenn Lautram; Florence Manero; Rodolphe Perrot; Chadi Abbara; Marie Briet; Samuel Legeay
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

5.  Evaluation of the intestinal transport of a phenylethanoid glycoside-rich extract from Cistanche deserticola across the Caco-2 cell monolayer model.

Authors:  Yuan Gao; Chuanjie Zong; Fen Liu; Lei Fang; Runlan Cai; Yue Shi; Xi Chen; Yun Qi
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

6.  Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments.

Authors:  Aroha B Sánchez; Ana C Calpena; Mireia Mallandrich; Beatriz Clares
Journal:  Pharmaceutics       Date:  2019-11-29       Impact factor: 6.321

7.  Inspired by the human placenta: a novel 3D bioprinted membrane system to create barrier models.

Authors:  Anna-Elisabeth Kreuder; Aramis Bolaños-Rosales; Christopher Palmer; Alexander Thomas; Michel-Andreas Geiger; Tobias Lam; Anna-Klara Amler; Udo R Markert; Roland Lauster; Lutz Kloke
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.